I was teaching in our #GenomeEngineering session of our MRC HGU graduate course about applications of #CRISPR technology, potential & limitations of #GenomeSurgery for #RareDisease on Monday- this excellent #ThoughtPiece by @urnov perfectly argued current #hurdles to applying revolutionary treatments because the regulatory, ethical and financial frameworks are moving slower than the tech- not for the benefit of patients. We need a new model for genomic medicines.
https://www.nytimes.com/2022/12/09/opinion/crispr-gene-editing-cures.html

